Form 4 for AHCO AdaptHealth Corp.
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-11 · accession 0000899243-22-011073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-15 | 2022-03-11+ | AHCO | Ebbel Matthew | Dir | P - Purchase | $15.35 | +42.5K | 2.48M | +2% | +$652.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-03-11 | P | A | 17,486 | $15.50 | 2,457,757 | D | — | — | (F1) Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| 2 | Common | Class A Common Stock | 2022-03-14 | P | A | 25,000 | $15.25 | 2,482,757 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.21 to $15.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. (F1) Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |